In addition, disruption of Smad3 prevents angiotensin II-induced kidney injury by preserving renal function, inhibiting renal fibrosis and inflammation, but has no effect on angiotensin II-induced high blood pressure in vivo [71]. This evidence concerns the gene AGT and hypertensive disorder.